Shilpa Medicare Limited has informed the Exchange about Retirement of Dr. Jayant Karajgi, Chief Operating Officer (COO) Formulations of the Company (SMP)

Management Changes View source PDF Explain this filing

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.3%Reaction day

₹412.00

prior close

₹407.90

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.2%+5.6% vs market

Pharmaceuticals peers, median of 161sector+0.3%+5.1% vs sector

On the reaction day the stock moved 5.6 pts more than Nifty Microcap 250 and 5.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.0

10m

+2.1

15m

+2.2

30m

+5.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.3-0.2+5.6+0.3+5.1

Next day

+0.0-1.6+1.6-0.6+0.6

+0.4+0.7-0.4+0.5-0.1

-0.7+0.6-1.3-0.0-0.7

-2.3+0.6-2.9-0.1-2.2

-0.5+0.2-0.7-0.3-0.2

+3.4+1.6+1.8+1.1+2.3

15d

+15.9+0.7+15.2+1.9+14.0

+24.9+3.1+21.8+4.7+20.2

+42.2+9.7+32.5+7.8+34.4

+46.6+8.3+38.3+6.8+39.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 161Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shilpa Medicare Limited has announced the retirement of Dr. Jayant Karajgi, who served as Chief Operating Officer (COO) - Formulations. The retirement became effective from the closing hours of 22 April 2026. With this departure, Dr. Karajgi also ceases to be classified as a Senior Management Personnel (SMP) of the company. The company has filed this disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, treating it as a material change in key managerial personnel.

Likely market impact

The departure of a senior operational leader like the COO of Formulations could create a leadership gap. Investors should monitor for announcement of a successor to assess continuity in the company's formulations business operations.